Point72 Asia (Singapore) Pte. Ltd. Ironwood Pharmaceuticals Inc Transaction History
Point72 Asia (Singapore) Pte. Ltd.
- $379 Billion
- Q4 2024
A detailed history of Point72 Asia (Singapore) Pte. Ltd. transactions in Ironwood Pharmaceuticals Inc stock. As of the latest transaction made, Point72 Asia (Singapore) Pte. Ltd. holds 8,022 shares of IRWD stock, worth $12,033. This represents 0.01% of its overall portfolio holdings.
Number of Shares
8,022Holding current value
$12,033% of portfolio
0.01%Shares
2 transactions
Others Institutions Holding IRWD
# of Institutions
244Shares Held
163MCall Options Held
11.5MPut Options Held
12.9K-
Black Rock Inc. New York, NY22.9MShares$34.3 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA19.5MShares$29.3 Million0.0% of portfolio
-
Sarissa Capital Management LP Greenwich, CT16.4MShares$24.6 Million22.5% of portfolio
-
Pacer Advisors, Inc. Malvern, PA11.7MShares$17.6 Million0.13% of portfolio
-
Armistice Capital, LLC New York, NY9.47MShares$14.2 Million0.59% of portfolio
About IRONWOOD PHARMACEUTICALS INC
- Ticker IRWD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 153,231,008
- Market Cap $230M
- Description
- Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adults suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC) under the LINZE...